Eisai and Imbrium Therapeutics announced that the Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for lemborexant, an investigational insomnia treatment.
This research supports the legitimacy of digital cognitive behavioral therapy as a treatment method for individuals with insomnia.
For pediatric patients with chronic pain, PTSD symptoms may be linked with higher levels of pain intensity.
Many cervical cancer survivors experience fatigue, insomnia, and hot flashes years later.
Doctors who prescribed a particular insomnia medication in the past were 3 times as likely to continue prescribing the same drug.
Overall, 26 of the 34 studies suggested a positive relationship between insomnia and depression.
After 10 years follow-up, researchers found that women who experienced surgical menopause were more likely to suffer worse insomnia symptoms.
American College of Physician researchers have released 2 recommendations for treatment of chronic insomnia disorder.
Young adults with sleep problems may be at higher risk for developing chronic pain or worsening pain severity.
Researchers suggest that there are more effective or adjunctive interventions to resolve symptoms of RBD.